Work

Phase 1 dose‐escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma

Year: 2010

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.25639

Authors: Brian I. Rini, Mark Stein, Pat Shannon, Simantini Eddy, Allison Tyler, Joe J. Stephenson, Lorie Catlett, Bo Huang, Diane Healey, Michael Gordon

Institutions: Cleveland Clinic, Rutgers Cancer Institute, Pinnacle Oncology Hematology, Pfizer (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2013683525

FWCI: 8.364

Cites: 14

Cited by: 154

Related to: 10